Medical technology leader Boston Scientific is working to restore global operations following a disruptive cyberattack on August 25 that impacted manufacturing, order processing, and product shipping capabilities.

Key Points

• Boston Scientific detected an unauthorized IT system intrusion on August 25, triggering a global network outage.
• The breach disrupted manufacturing and shipping, though existing implantable cardiac devices remain unaffected by the incident.
• Remote activations for certain cardiac monitors were temporarily halted due to the network disruption.
• Cybersecurity firm CrowdStrike is assisting the company with an ongoing investigation into the breach.
• The company reported no new malicious activity since the initial detection and aims to resume partial shipping this week.

Why it Matters

This incident highlights the significant operational vulnerabilities medical device manufacturers face when critical IT infrastructure is compromised. The disruption underscores the broader risks to global supply chains and patient care services when essential technology systems are taken offline by cyberattacks.